MyFinsight
Home
Blog
About
Contact
Download
Download image
United States Segment
$937,600K
(11.77%↑ Y/Y)
Europe Segment
$442,600K
(29.49%↑ Y/Y)
Rest Of World Segment
$177,800K
(18.38%↑ Y/Y)
Japan Segment
$90,600K
(10.76%↑ Y/Y)
Net sales
$1,648,600K
(16.70%↑ Y/Y)
Gross profit
$1,286,000K
(15.74%↑ Y/Y)
Other operating
income
$14,200K
(-25.65%↓ Y/Y)
Cost of sales
$362,600K
(20.23%↑ Y/Y)
Operating income, net
$477,600K
(20.97%↑ Y/Y)
Other non-operating
income, net (note7)
$71,500K
(2650.00%↑ Y/Y)
Interest income, net
$33,500K
(-8.22%↓ Y/Y)
Selling, general, and
administrative expenses
$522,200K
(12.13%↑ Y/Y)
Research and development
expenses
$263,300K
(3.42%↑ Y/Y)
Certain litigation
expenses
$37,100K
(240.37%↑ Y/Y)
Income from continuing
operations before...
$459,000K
(5.78%↑ Y/Y)
Loss on impairment
(note 6)
$123,600K
Net income from
continuing operations
$380,700K
(4.70%↑ Y/Y)
Provision for income taxes
$78,300K
(11.38%↑ Y/Y)
Net income
$380,700K
(6.82%↑ Y/Y)
Net income
attributable to edwards...
$380,700K
(6.34%↑ Y/Y)
Back
Back
Income Statement
logo (34)-svg
Edwards Lifesciences Corp (EW)
logo (34)-svg
source: myfinsight.com
Edwards Lifesciences Corp (EW)